S.O.2859 (E) dated 16/07/2021-Amendment in EIA Notification, 2006

Che Gazette of India .3 2r.ua.-31.-16072021-228338 EXTRAORDINARY TR &y PUBLISHED BY AUTHORITY No. 2653] NEW DELHL FRIDAY, JULY 16, 2021/ASHADHA 25,1943 7% R, 16 are, 2021 FEALHT HUT ATNT AT T AT T, F1.41. 3636(3A), AT 15 wzaw, 2020 T FE W F fory 30 fRre=re, 2020 ¥ 30 ==, 2021 T FEET AT ; ATTFATE ; 3928 GI/)2021 (1) A araeFaT 7 gftana Taw gu, U AT AT T FIAT ATAF THAATE A, I, T AT, TATC (FET) Afdfr=, 1986 (1986 FT 29) i arer 3 Fr gwemer (1) T 3 ALEATT FIAT SO 1" [, . 22-25/2020-ar5T- )] o o o .41, 1533(a), AT 14 forwae, 2006 FreT wiera £7 TE i e ifqw wona aftrg=r TEAT FTAT. 2817 (&), AT 13 JATE, 2021 1T R AT | MINISTRY OF ENVIRONMENT, FOREST AND CLIMATE CHANGE NOTIFICATION New Delhi, the 16th July, 2021 S.0. 2859(E).—Whereas, the Central Government, in exercise of its powers by sub-section (1) and clause (v) of sub-section (2) of section 3 of the Environment (Protection) Act, 1986 has published the Environment Impact Assessment Notification, 2006 vide number S.O. 1533(E), dated the 14th September, 2006, (hereinafter referred to as the said notification) making the requirement of prior environmental clearance from the concerned regulatory authority mandatory for all new projects or activities listed in the Schedule to the said notification, their expansion and modernisation and/or change in product mix, as the case may be, before any construction work or preparation of land by the project management except for securing the land; And Whereas, in view of the CoVID-19 pandemic and the requirement to expedite drug manufacturing the ‘said notification’ was amended vide notification no. S.0. 1223(E), dated 27th March, 2020 wherein it was notified that all proposals for projects or activities in respect of Active Pharmaceutical Ingredients (API), received up to 30th September, 2020, shall be appraised as Category ‘B2’ projects. Subsequently, the above mentioned period was extended by six months from 30th September, 2020 to 30th March, 2021 vide notification no. S.0. 3636(E) dated 15th October, 2020; And Whereas, in view of the outbreak of the second wave of COVID-19 pandemic, the Central Government has received requests for further extension of the time period beyond 30th March, 2021 as there is a continued requirement to expedite drug manufacturing; And Whereas, the Central Government deems it necessary to provide another window in view of the second wave of COVID-19 pandemic and continued requirement of expeditious drug manufacturing; Now, Therefore, in exercise of powers conferred by sub-section (1) and clause (v) of sub-section (2) of section 3 of the Environment (Protection) Act, 1986 (29 of 1986), the Central Government, hereby makes following further amendments in the said notification, namely:- In the said notification, in the Schedule, against item 5(f), in column (5), for the third paragraph the following paragraph shall be substituted, namely:- “All proposals for projects or activities in respect of Active Pharmaceutical Ingredients (4API), received from 16th July, 2021 to 31st December, 2021, shall be appraised, as Category ‘B2’ projects, provided that any subsequent amendment or expansion or change in product mix, after the 31st December, 2021, shall be considered as per the provisions in force at that time.” Note : The principal notification was published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (ii) vide number S.0. 1533(E), dated the 14th September, 2006 and was last amended vide the notification number S.O. 2817(E), dated the 13th July, 2021. and Published by the Controller of Publications, Delhi-110054. ALOK KUMAR 2o